top of page

Zydus receives final approval from the USFDA for Misoprostol Tablets

Writer's picture: Sanjay TrivediSanjay Trivedi

Zydus Cadila has received the final approval from the USFDA to market Misoprostol Tablets (US RLD – Cytotec®), 100 mcg and 200 mcg. Misoprostol is used to prevent stomach ulcers in patients taking pain medications especially if the patient is at risk for developing ulcers or has a past history of ulcers. Misoprostol helps to decrease risk of serious ulcer complications such as bleeding. The drug will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad. The group now has 268 approvals and has so far filed over 360 ANDAs since the commencement of the filing process in FY 2003-04.

4 views0 comments

Recent Posts

See All

CSIR Developed Anti-Diabetes Medicine

The diabetic population in the country is close to hitting the alarming mark of 69.9 million by 2025, which denotes that the country is...

Contact

Follow

+91 - 90999 81023

©2017 by Accuprec News. Proudly created with Wix.com

©Copyright
bottom of page